| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Adrenaline (base) 10mg/10ml (1 in 1,000) solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Normal immunoglobulin human 1g/6ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Articaine 88mg/2.2ml / Adrenaline (base) 11micrograms/2.2ml (1 in 200,000) solution for injection cartridges |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Iohexol 647mg/ml (Iodine 300mg/ml) solution for injection 500ml plastic bottles |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Iohexol 755mg/ml (Iodine 350mg/ml) solution for injection 500ml plastic bottles |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Phenol 7.5% in Glycerol solution for injection 5ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Generic Mydrane 0.2mg/ml / 3.1mg/ml / 10mg/ml solution for injection 0.6ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Protirelin 200micrograms/1ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ixekizumab 80mg/1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ixekizumab 80mg/1ml solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Caffeine 250mg/2ml / Sodium benzoate 250mg/2ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sodium chloride 0.9% solution for injection 5ml ampoules (Unichem Plc) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Arthrease injection 2ml pre-filled syringes (Depuy International Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Steri-Amp sodium chloride 0.9% solution for injection 5ml ampoules (Steripak Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Imigran Subject 6mg/0.5ml solution for injection syringe refill pack (GlaxoSmithKline) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Mini-Plasco sodium chloride 0.9% solution for injection 5ml ampoules (B.Braun Medical Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ergocalciferol 300,000units/1ml solution for injection ampoules (Unichem Plc) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sure-Amp lidocaine 100mg/10ml (1%) solution for injection ampoules (Antigen Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Mini-Plasco lidocaine 100mg/10ml (1%) solution for injection ampoules (B.Braun Medical Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 50% solution for injection 2ml ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Aranesp 30micrograms/0.3ml solution for injection pre-filled syringes (Amgen Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Aranesp 60micrograms/0.3ml solution for injection pre-filled syringes (Amgen Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Puregon 600units/0.72ml solution for injection cartridges (Organon Pharma (UK) Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Somatuline Autogel 90mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hypurin Porcine Neutral 100units/ml suspension for injection 3ml cartridges (C P Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Dexamethasone sodium phosphate 10mg/2ml solution for injection vials (Organon Laboratories Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Dexamethasone sodium phosphate 5mg/1ml solution for injection ampoules (Organon Laboratories Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Dexamethasone phosphate 8mg/2ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Narcan 400micrograms/1ml solution for injection ampoules (Bristol-Myers Squibb Pharmaceuticals Limited) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Papaveretum 15.4mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Konakion MM 10mg/1ml solution for injection ampoules (Neon Healthcare Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tetabulin 250units/1ml solution for injection pre-filled syringes (Baxter Healthcare Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Viraferon 30million units/1.2ml solution for injection multidose pens (Schering-Plough Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Calcium folinate 3mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Naloxone 2mg/2ml solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Cytarabine 20mg/ml solution for injection vials (Pfizer Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Doxorubicin 50mg/25ml solution for injection vials (Unichem Plc) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Anapen Junior 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Bioprojet UK Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Calcium folinate 300mg/30ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Oily phenol 5% solution for injection 5ml ampoules (Unichem Plc) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tobramycin 40mg/1ml solution for injection vials (A A H Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Fluorouracil 1g/20ml solution for injection vials (Mayne Pharma Plc) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Fluorouracil 1g/20ml solution for injection vials (Medac GMBH) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| D-Gam Anti-D immunoglobulin 1,500unit solution for injection vials (BPL (Bio Products laboratory)) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Lidocaine 100mg/10ml (1%) solution for injection ampoules (hameln pharma Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Vaminolact solution for injection 500ml bottles (Fresenius Kabi Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hypnomidate 20mg/10ml solution for injection ampoules (Janssen-Cilag Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Niopam 200 solution for injection 50ml bottles (Bracco UK Limited) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ultravist 370 solution for injection 75ml bottles (Schering Health Care Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ultravist 370 solution for injection 100ml bottles (Schering Health Care Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Visipaque 270 solution for injection 200ml bottles (Amersham Health) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Visipaque 270 solution for injection 40ml bottles (Amersham Health) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Visipaque 320 solution for injection 40ml bottles (Amersham Health) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnevist 0.5mmol/ml solution for injection 20ml vials (Schering Health Care Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Omnipaque 300 solution for injection 10ml vials (GE Healthcare Biosciences) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Omnipaque 300 solution for injection 75ml bottles (GE Healthcare Biosciences) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Omnipaque 350 solution for injection 100ml plastic bottles (GE Healthcare Biosciences) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hypaque 25% solution for injection 20ml vials (Esteve Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hypaque 45% solution for injection 20ml ampoules (Esteve Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Aranesp SureClick 500micrograms/1ml solution for injection pre-filled pens (Amgen Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Aranesp SureClick 20micrograms/0.5ml solution for injection pre-filled pens (Amgen Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Methotrexate 17.5mg/0.7ml solution for injection pre-filled syringes (Special Order) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Methotrexate 10mg/0.4ml solution for injection pre-filled syringes (Special Order) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Subgam 1.5g/10ml solution for injection vials (BPL (Bio Products laboratory)) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Minijet morphine sulphate 10mg/10ml solution for injection pre-filled syringes (UCB (Pharma) Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Naloxone 400micrograms/1ml solution for injection ampoules (Wockhardt UK Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Litak 10 solution for injection vials (Lipomed Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Androcur Depot 300mg/3ml solution for injection ampoules (Schering Health Care Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| E-Vicotrat 100mg/2ml solution for injection ampoules (Heyl Chem-pharm Fabrik GmbH & Co. KG) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Calcium folinate 100mg/10ml solution for injection vials (Wockhardt UK Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sodium chloride 0.9% solution for injection 10ml ampoules (Goldshield Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Lidocaine 100mg/10ml (1%) solution for injection ampoules (Goldshield Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Vitamin B6 Streuli 100mg/2ml solution for injection ampoules (G. Streuli & Co. AG) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Apidra 100units/ml solution for injection 3ml OptiClik cartridges (sanofi-aventis) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Viper venom antiserum, European (equine) 1g/10ml solution for injection vials (Institute of Immunology, Inc) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Levemir Penfill 100units/ml solution for injection 3ml cartridges (Waymade Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Puregon 150units/0.5ml solution for injection vials (Waymade Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Biodermatin 5mg/1ml solution for injection vials (La.Fa.Re. SRL) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Synocrom Mini 10mg/ml injection 1ml pre-filled syringes (Dee Pharmaceuticals Ltd) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Tolazoline 25mg/1ml solution for injection ampoules (Special Order) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Byetta 5micrograms/0.02ml solution for injection 1.2ml pre-filled pens (AstraZeneca UK Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Aethoxysklerol 80mg/2ml solution for injection ampoules (Chemische Fabrik Kreussler & Co. GmbH) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| ProHance 0.5mmol/ml solution for injection 17ml pre-filled syringes (Bracco UK Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Dynepo 2,000units/0.5ml solution for injection pre-filled syringes (Shire Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Dynepo 6,000units/0.3ml solution for injection pre-filled syringes (Shire Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Dynepo 8,000units/0.4ml solution for injection pre-filled syringes (Shire Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Aranesp SureClick 130micrograms/0.65ml solution for injection pre-filled disposable devices (Amgen Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Pethidine 100mg/1ml solution for injection ampoules (Special Order) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Eprex 30,000units/0.75ml solution for injection pre-filled syringes (Janssen-Cilag Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| NovoRapid FlexPen 100units/ml solution for injection 3ml pre-filled pens (Dowelhurst Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Abilify 9.75mg/1.3ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Retacrit 2,000units/0.6ml solution for injection pre-filled syringes (Hospira UK Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Retacrit 5,000units/0.5ml solution for injection pre-filled syringes (Hospira UK Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Retacrit 6,000units/0.6ml solution for injection pre-filled syringes (Hospira UK Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Japanese encephalitis GCVC vaccine solution for injection 10ml vials (Imported (Korea)) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| EpiPen Jr. 150micrograms/0.3ml (1 in 2,000) solution for injection auto-injectors (Sigma Pharmaceuticals Plc) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ratiograstim 30million units/0.5ml solution for injection pre-filled syringes (Ratiopharm UK Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Bridion 200mg/2ml solution for injection vials (Merck Sharp & Dohme (UK) Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Firazyr 30mg/3ml solution for injection pre-filled syringes (Takeda UK Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Stelara 45mg/0.5ml solution for injection vials (Janssen-Cilag Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| OxyNorm 50mg/1ml solution for injection ampoules (Napp Pharmaceuticals Ltd) |
Has manufactured dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|